FDA releases the form FDA-483 with 13 observations from an April inspection at China’s Zhejiang Hushai Pharmaceutical Co.
The American Society of Health System Pharmacists says there were 227 active drug shortages in the second quarter of 2026, trending up for the third quarter in a row.
FDA releases the form FDA-483 with 13 observations from an April inspection at China’s Zhejiang Hushai Pharmaceutical Co.
The American Society of Health System Pharmacists says there were 227 active drug shortages in the second quarter of 2026, trending up for the third quarter in a row.
Rep. Diana DeGette (D-CO) wins FDA assurances that several policy announcements issued during former commissioner Marty Makary's tenure — including articles published in medical journals and media interviews— are not intended to be recognized as official agency guidance.
FDA releases the form FDA-483 with five observations from an inspection at Iceland’s Alvotech EF.
